We are delighted to share that Eupnoos, a One Health Portfolio company, has received the prestigious Serge Weinberg Trophy from the Sanofi Foundation S, Future4Care, and 21st by CentraleSupélec. This honour recognises Eupnoos’s dedication to advancing research in critical yet underfunded areas of healthcare, particularly airways disease.
Eupnoos is a pioneering health-tech company that leverages audio-phenotyping technology to transform lung health diagnostics. By converting smartphones into mobile acoustic labs, Eupnoos’s platform captures and analyses breath sound patterns, identifying unique biomarkers indicative of respiratory diseases such as asthma and COPD. This innovative approach allows for swift, precise, and cost-effective diagnoses, offering a significant improvement over traditional methods. With a mission to provide accessible and affordable chronic cardiopulmonary disease screening, Eupnoos is at the forefront of advancing respiratory healthcare.
Categories: News